The fertility services sector demonstrated remarkable resilience over the course of 2020 in the face of a global pandemic that disrupted nearly every aspect of the world as we know… Read more »
Transaction will fuel global expansion of Mosaic’s industry-leading multiplex immunohistochemistry services supporting targeted drug development Intrepid announced today that it served as the exclusive financial advisor to Mosaic Laboratories L.L.C…. Read more »
Intrepid congratulates Gary Rabishaw, Adam Abramowitz, and Brandon Quartararo for being selected by the Los Angeles Business Journal as “Leaders of Influence” in the Investment Bankers 2020 special issue. Gary… Read more »
The recent merger of Teladoc and Livongo is expected to accelerate the current explosion in digital health M&A and propel virtual services to become the “new normal”. Intrepid’s Healthcare and… Read more »
The pandemic is putting the diagnostics sector in the spotlight again. How have current events impacted the sector and what influence will they have on M&A and investment trends? Intrepid’s… Read more »
As we contemplate re-opening the healthcare industry and the broader economy, we are pleased to share best practice observations and guidance from some of our country’s leading healthcare visionaries. Intrepid’s… Read more »
What conversations are going on in healthcare boardrooms right now? How will the COVID-19 crisis impact healthcare dealmaking? What sectors will private equity investors and strategic buyers continue to target? … Read more »
COVID-19 has abruptly halted the success of many in the Physician Practice Management (PPM) sector but, contrary to popular opinion, good PPM companies can still transact. Intrepid’s Healthcare team has… Read more »
Creating an Innovation Leader in Concierge Medicine Intrepid announced today that it acted as the exclusive financial advisor to Paragon Private Health, LLC (Paragon), on its merger with SignatureMD, Inc…. Read more »
Turning Point: COVID-19 Highlights How Important Diagnostics Will Be to Our Future The criticism of the United States’ initial limited COVID-19 diagnostic testing has given way to a much-needed clarion… Read more »
